PROTECT – Trial: A cluster RCT to study the effectiveness of a repositioning aid and tailored repositioning to increase repositioning compliance

摘要

Abstract Aim To study the effectiveness of tailored repositioning and a turning and repositioning system on: (a) nurses’ compliance to repositioning frequencies; (b) body posture of patients after repositioning; (c) incidence of pressure ulcers and incontinence‐associated dermatitis; (d) nurses’ and patients’ preferences, comfort and acceptability; and (e) budget impact. Background Patient‐tailored systematic repositioning is key in pressure ulcer prevention. To date, a clinical decision‐making tool is lacking and compliance to pressure ulcer prevention guidelines is low. Research concerning commercially available turning and repositioning systems is lacking. Design Multicentre, cluster, three‐arm, randomized, controlled pragmatic trial. Methods Two hundred and twenty‐seven patients at risk of pressure ulcer development were recruited at 29 wards in 16 hospitals between February 2016 and December 2017. Wards were randomly assigned to two experimental groups and one control group. Results Nurses’ compliance to repositioning frequencies increased significantly in the experimental groups when patients were cared for in bed (94.6% vs. 69% and 84.9% vs. 71.4%). Applying the turning and repositioning system was associated with significantly more correctly positioned patients (30–45° tilted side‐lying position) (69.6% vs. 34.6%). Few pressure ulcers and incontinence‐associated dermatitis incidents occurred. Both patients and nurses were positive about the intervention. Higher labour costs related to repositioning in bed were found in the control group. Conclusion This was the first study investigating the effect of tailored repositioning and the use of a repositioning aid to increase nurses’ compliance to repositioning. The results were in favour of the interventions yet demonstrating the importance of follow‐up and education. Trial registration This study is registered at https://clinicaltrials.gov/NCT02690753 ; NCT 02690753.